Folgen
Elliot Israel
Elliot Israel
Professor of Medicine, Harvard Medical School Brigham and Women's Hospital
Bestätigte E-Mail-Adresse bei partners.org
Titel
Zitiert von
Zitiert von
Jahr
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program
WC Moore, DA Meyers, SE Wenzel, WG Teague, H Li, X Li, ...
American journal of respiratory and critical care medicine 181 (4), 315-323, 2010
25342010
Treatment of asthma with drugs modifying the leukotriene pathway
JM Drazen, E Israel, PM O'Byrne
New England Journal of Medicine 340 (3), 197-206, 1999
11531999
Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program
WC Moore, ER Bleecker, D Curran-Everett, SC Erzurum, BT Ameredes, ...
Journal of Allergy and Clinical Immunology 119 (2), 405-413, 2007
10352007
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations
DG Torgerson, EJ Ampleford, GY Chiu, WJ Gauderman, CR Gignoux, ...
Nature genetics 43 (9), 887, 2011
9022011
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial
M Castro, AS Rubin, M Laviolette, J Fiterman, M De Andrade Lima, ...
American journal of respiratory and critical care medicine 181 (2), 116-124, 2010
8972010
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
JM Drazen, CN Yandava, L Dubé, N Szczerback, R Hippensteel, A Pillari, ...
Nature genetics 22 (2), 168-170, 1999
7421999
Significant variability in response to inhaled corticosteroids for persistent asthma
SJ Szefler, RJ Martin, TS King, HA Boushey, RM Cherniack, VM Chinchilli, ...
Journal of Allergy and Clinical Immunology 109 (3), 410-418, 2002
7352002
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
E Israel, VM Chinchilli, JG Ford, HA Boushey, R Cherniack, TJ Craig, ...
The Lancet 364 (9444), 1505-1512, 2004
7322004
Tiotropium bromide step-up therapy for adults with uncontrolled asthma
SP Peters, SJ Kunselman, N Icitovic, WC Moore, R Pascual, BT Ameredes, ...
New England Journal of Medicine 363 (18), 1715-1726, 2010
7062010
The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma
E Israel, JM Drazen, SB Liggett, HA Boushey, RM Cherniack, ...
American journal of respiratory and critical care medicine 162 (1), 75-80, 2000
6962000
Interleukin-17–producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity
HY Kim, HJ Lee, YJ Chang, M Pichavant, SA Shore, KA Fitzgerald, ...
Nature medicine 20 (1), 54-61, 2014
6522014
Unjamming and cell shape in the asthmatic airway epithelium
JA Park, JH Kim, D Bi, JA Mitchel, NT Qazvini, K Tantisira, CY Park, ...
Nature materials 14 (10), 1040-1048, 2015
5742015
Tezepelumab in adults and adolescents with severe, uncontrolled asthma
A Menzies-Gow, J Corren, A Bourdin, G Chupp, E Israel, ME Wechsler, ...
New England Journal of Medicine 384 (19), 1800-1809, 2021
5492021
Daily versus as-needed corticosteroids for mild persistent asthma
HA Boushey, CA Sorkness, TS King, SD Sullivan, JV Fahy, SC Lazarus, ...
New England Journal of Medicine 352 (15), 1519-1528, 2005
5392005
Severe and difficult-to-treat asthma in adults
E Israel, HK Reddel
New England Journal of Medicine 377 (10), 965-976, 2017
5332017
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma
SC Lazarus, VM Chinchilli, NJ Rollings, HA Boushey, R Cherniack, ...
American journal of respiratory and critical care medicine 175 (8), 783-790, 2007
5322007
COVID-19–related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids
MC Peters, S Sajuthi, P Deford, S Christenson, CL Rios, MT Montgomery, ...
American journal of respiratory and critical care medicine 202 (1), 83-90, 2020
5232020
Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma
C Barnig, M Cernadas, S Dutile, X Liu, MA Perrella, S Kazani, ...
Science translational medicine 5 (174), 174ra26-174ra26, 2013
4962013
The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin
E Israel, AR Fischer, MA Rosenberg, CM Lilly, JC Callery, J Shapiro, ...
American Review of Respiratory Disease 148 (6_pt_1), 1447-1451, 1993
4901993
Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial
SC Lazarus, HA Boushey, JV Fahy, VM Chinchilli, RF Lemanske Jr, ...
Jama 285 (20), 2583-2593, 2001
4762001
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20